ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta

56.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 56.00 55.00 57.00 56.00 56.00 56.00 168,506 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 23.25M -24.95M -0.0695 -8.06 201.06M
Avacta is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 56p. Over the last year, Avacta shares have traded in a share price range of 39.75p to 114.00p.

Avacta currently has 359,042,104 shares in issue. The market capitalisation of Avacta is £201.06 million. Avacta has a price to earnings ratio (PE ratio) of -8.06.

Avacta Share Discussion Threads

Showing 79651 to 79666 of 81075 messages
Chat Pages: Latest  3195  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  Older
DateSubjectAuthorDiscuss
09/4/2024
21:49
It's probably likely that all of these patients participating in the trial should be dead by now. They were terminal with only a few months left to live. This is why they were selected for this extremely risky safety trial. The safety trial wasn't expected to help them. It's just to test safety. These selfless people have been given a small miracle with AVA6000. Just hope they continue to recover further.
rajraj b
09/4/2024
21:23
We will need the actual data to understand this. Wait for the seminar at 5.30pm.
bonzo
09/4/2024
21:12
Are you still in ama or buying back in the morning? Still here. Where's whitey?
cheshire pete
09/4/2024
21:03
On second thoughts !!,perhaps it should be called the "Lazarus" drug !

One patient managed his 60th birthday against the odds !!

fieldhouse
09/4/2024
20:57
Well, a bit disappointing !! No Lazarus Effect !!
Can't quite bring back the dead !!
Can do Just what they said on the can !!

Very happy to hold . The science is good .Take note company mockers

fieldhouse
08/4/2024
12:06
Any future for this company?? Years after years no results & no revenues
blackhorse23
08/4/2024
10:40
Lol. Obviously tongue in cheek
coley15
08/4/2024
10:32
...says the trader
conviboyz
08/4/2024
09:22
The traders return. Shallow as an eight inch puddle. Devious spawn.
amanitaangelicus
06/4/2024
12:49
..talking of double bottoms. How are you and Baldrick getting on
conviboyz
06/4/2024
11:45
A very bullish tweet by the Head of R&D re next week's presentation: https://x.com/coughlin582/status/1776403692343759065?s=46&t=6L3i5L2B0LVcI0QnNB2C4A
northwards
06/4/2024
00:35
Ooo woooopy blooody dooo, more blooody jargen
repins1
05/4/2024
13:58
Jeez beatme1 - don't you have a spellchecker?
wsm812
05/4/2024
13:31
"is regurgitates bull" ?
coley15
05/4/2024
13:18
Hdmtwww!.£/!: d
beatme1
04/4/2024
15:13
40-45p ...big double bottom on the 3 yr. If the share price can recover on news, there.s a nice gap that needs filling. Mkt cap still around £125m - that.ll include cash in bank. Still too high for where we.re at. No way we.ll get through to 2025 end stages without more raises, once the current placing has been burned through. Convis playing havoc at the mo. Until the rest is set, nobody will be interested. TimeLord Smith will have had to give reassurances to the ii.s who took the recent offer up. What those assurances were, one can only guess. Rest assured, you.ll be the last to know.
amanitaangelicus
Chat Pages: Latest  3195  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  Older